In Brief
Memory CD4 + T cells contribute to longterm immunity against pathogens. Ciucci et al. show that the transcription factor Thpok is essential to safeguard the memory potential of early pathogenresponding CD4 + T cells and serves by antagonizing a Blimp1-and Runx3-driven dysfunction transcriptional circuitry.
SUMMARY
Memory CD4 + T cells mediate long-term immunity, and their generation is a key objective of vaccination strategies. However, the transcriptional circuitry controlling the emergence of memory cells from early CD4 + antigen-responders remains poorly understood. Here, using single-cell RNA-seq to study the transcriptome of virus-specific CD4 + T cells, we identified a gene signature that distinguishes potential memory precursors from effector cells. We found that both that signature and the emergence of memory CD4 + T cells required the transcription factor Thpok. We further demonstrated that Thpok cellintrinsically protected memory cells from a dysfunctional, effector-like transcriptional program, similar to but distinct from the exhaustion pattern of cells responding to chronic infection. Mechanistically, Thpok-bound genes encoding the transcription factors Blimp1 and Runx3 and acted by antagonizing their expression. Thus, a Thpok-dependent circuitry promotes both memory CD4 + T cells' differentiation and functional fitness, two previously unconnected critical attributes of adaptive immunity.
INTRODUCTION
Immunological memory, the ability to mount a fast secondary effector response to a new challenge by a previously encountered pathogen, is a defining property of the adaptive immune system, and it relies on long-lived antigen-specific B and T cells. T cells responding to an initial infection undergo extensive proliferation, giving rise to effector populations that promote pathogen clearance. After a contraction phase when most effector T cells die by apoptosis, memory T cells survive and provide long-lasting protection against reinfection.
In addition to promoting CD8 + T cell and B cell memory responses, CD4 + T cells give rise to memory populations essential for durable immunity (Laidlaw et al., 2016; MacLeod et al., 2009) , including against human influenza, malaria, and Leishmania infection (Mordm€ uller et al., 2017; Wilkinson et al., 2012; Zaph et al., 2004) . Although most antigen-responding CD4 + T cells have the potential to give rise to short-lived effector and longlived memory cells (Cho et al., 2017; Tubo et al., 2016) , what controls the emergence and functional fitness of memory CD4 + cells remains poorly understood. Unlike for memory CD8 + T cells, whose precursors can be identified early during the immune response (e.g., through their expression of interleukin-7 receptor ), identifying putative precursors of memory CD4 + T cells has been challenging (Ahmed et al., 2009; Marshall et al., 2011; . One perspective holds that ''memory precursors'' diverge from short-term effectors early during the immune response, notably by restraining expression of differentiation programs (including interferon-g [IFNg]-expressing T helper-1 [Th1] cells) specific to effector fates and maintaining expression of genes characteristic of undifferentiated cells; supporting this idea, studies have identified specific CD4 + T cell subsets that exhibit higher potential for memory differentiation (Cho et al., 2017; L€ uthje et al., 2012; Marshall et al., 2011; Nish et al., 2017; . However, there is support for the possibility that differentiated effectors can give rise to long-lived memory cells (Fazilleau et al., 2009; Harrington et al., 2008; Marshall et al., 2011; McKinstry et al., 2014) . Here, we have taken advantage of single-cell RNA sequencing (scRNA-seq) to characterize the gene expression programs underpinning the heterogeneity of T cell responses and the development of memory T cells. Analyzing CD4 + T cells at the peak of their response to an acute viral infection, we identified a transcriptional signature characteristic of potential memory-cell precursors. We found that both the emergence of this signature and the generation of a durable and effective memory CD4 + response required the transcription factor Thpok, which notably prevented the establishment of a dysfunction gene-expression pattern characteristic of short-lived effector cells. Mechanistically, Thpok protected memory development by restraining the expression of the transcription factors Runx3 and Blimp1 and bound to chromatin regions within or near these genes. Thus, a Thpok-dependent transcriptional circuitry controls the emergence of a memory program in early CD4 + T cell responders, and it is critical for the establishment of durable and effective CD4 + T cell memory.
RESULTS
Single-Cell RNA-Seq Identifies the Signature of a CD4 +
T Cell Memory Precursor
We performed scRNA-seq to dissect early T cell responses against the Armstrong strain of Lymphocytic ChorioMeningitis Virus (LCMV Arm), which in wild-type (WT) mice is cleared by innate and CD8 + T cells (Matloubian et al., 1994) . At 7 days post-infection (dpi), we used the droplet-based GemCode Chromium technology ( Figure 1A ) (Zheng et al., 2017) ) to capture non-naive (CD44 hi ) spleen T cells, which included LCMV-reactive cells and pre-existing memory cells of unrelated specificity. We first analyzed 7,006 cells, each expressing an average of 1,446 genes (Table S1 ). Visualization with t-distributed stochastic neighbor embedding (t-SNE), which positions cells on the basis of similarity in gene expression, revealed a clear demarcation between CD4 + and CD8 + T cells, as well as negligible contamination by non-T cells ( Figure S1A ). Subsequent analyses were carried out on CD4 + T cells only and were aimed at identifying cell subsets defined by specific gene expression signatures. Unsupervised clustering of CD44 hi CD4 + T cells (2,782 cells) identified 6 clusters (clusters A1-F1) matching the known heterogeneity of this population (Hale et al., 2013; Marshall et al., 2011) (Kaech et al., 2002; Marshall et al., 2011) . Cluster D1's high expression of Il7r, a gene minimally expressed at 7 dpi in virus-specific CD4 + T cells (Purton et al., 2007) , suggested that it mostly included pre-existing memory cells (Tmem) unrelated to LCMV infection. For each cluster, we computed signatures based on genes differentially expressed between that cluster and all others. Using the same approach on an independent replicate of 956 CD44 hi CD4 + spleen T cells at 7 dpi (Table S1 ), we identified eight clusters ( Figure S1C ); five of these (A2-E2) had gene expression signatures closely matching those that were identified for clusters A1-E1 in the first replicate, highlighting the robustness of this analysis. There was less similarity between clusters F1 and F2-H2, which could not be assigned a specific signature ( Figure S1D ). Thus, we defined Th1, Tfh, Treg, and Tmem cell signatures as the intersection of corresponding gene signatures defined in each replicate ( Figure 1D and Table S2 ). In addition, the signature defined by clusters C1 and C2 comprised genes (including Tcf7 [encoding TCF-1], Bcl2 or Ccr7, but not Il7r) typical of memory cells, and it excluded typical Tfh and Th1 cell effector genes. Because CCR7-expressing CD4 + T cell responders have an increased potential to become memory cells (Cho et al., 2017; He et al., 2013; Marshall et al., 2011; Sallusto et al., 1999) , we speculated that this signature, which we designated T central memory precursor (Tcmp), identified a gene expression program related to memory potential. To unambiguously assess virus-specific cells, we performed scRNA-seq at 7 dpi on CD4 + spleen T cells specific for the LCMV glycoprotein-derived GP66 peptide complexed to I-A b MHC-II molecules ( Figure 1E and Table S1 ). We clustered this LCMV-specific population and scored CD4 + T cells in every cluster for each gene signature we had previously defined (Figures 1F and 1G) . GP66-specific cells were separated into clusters with high scores for Th1 (clusters I-III), Tfh (cluster V), and Tcmp (cluster VIII) cell signatures (Figures 1G and S1E) . In contrast, GP66-specific cells showed little or no enrichment for the Treg cell signature, consistent with the lack of a Foxp3 + Treg cell component in the GP66-specific response (Crawford et al., 2014) (Figures S1F andS1G) . GP66-specific cells also scored low for the Tmem cell signature ( Figure S1H ), in agreement with the idea that this signature identifies memory or memory-like cells that were not reactive against a pre-existing infection with LCMV. Additional clusters partially matched these well-defined signatures but were not robustly identified across experiments ( Figures 1D and 1G ), suggesting functional plasticity among early CD4 + T cell responders.
However, high scores for Tfh and Tcmp cell signatures were mutually exclusive ( Figures 1D, 1G , S1E, and S1I) even though expression of specific genes (e.g., Cxcr5 and Tcf7) was observed in clusters corresponding to each signature. Taken together, these scRNA-seq analyses identified a specific Tcmp cell transcriptomic signature, distinct from that of differentiated effector cells and highly enriched in a CCR7-expressing subset known to have elevated CD4 + T cell memory potential. The demarcation between Tfh and Tcmp cell signatures matched the separation between CCR7 -CXCR5 + (Tfh) and CCR7 + CXCR5 + cells in flow cytometry analyses ( Figure 1H) ; thus, subsequent experiments used co-expression of both receptors to identify cells-with elevated memory potential. Of note, some Th1 cells had positive scores for genes of the Tcmp cell signature ( Figures S1D and S1I ), highlighting the fact that the expression of Th1 cell-associated genes does not exclude conservation of memory potential, as previously noted (Harrington et al., 2008; Marshall et al., 2011; Nish et al., 2017; Tubo et al., 2016) .
The Tcmp Cell Signature Is Thpok Dependent
We sought genetic evidence to support the functional significance of the Tcmp cell signature. We noted that there are substantial differences between CD4 + and CD8 + memory T cells (Crawford et al., 2014; Homann et al., 2001; Schiemann et al., 2003) ; accordingly, no 7 dpi LCMV CD8 + T cell cluster scored high for the Tcmp cell signature (data not shown). Because the transcription factor Thpok promotes CD4 + T cell differentiation in the thymus and because its expression remains largely specific of CD4 + T cells after thymic egress (Carpenter and Bosselut, 2010; He et al., 2005; Sun et al., 2005) , we inquired whether Thpok was necessary for the expression of the Tcmp cell signature. We analyzed the single-cell transcriptome of LCMV-specific CD4 + T cells deficient for Zbtb7b
(encoding Thpok) by using Zbtb7b fl/fl mice carrying a cre cDNA that was genetically targeted into Tnfrsf4 (encoding Ox40) and designated Zbtb7b AD (for ''activation-induced deletion''). In these mice, Cre was preferentially expressed in antigen-activated post-thymic CD4 + T cells ( Figure S2A ), therefore leaving naive conventional CD4 + T cells untouched. These mice carried a Rosa26 YFP allele to identify Cre-expressing cells (Srinivas et al., 2001) , and cells subject to scRNA-seq were sorted for yellow fluorescent protein (YFP) expression. 
(legend continued on next page)
Thpok deletion in Zbtb7b AD mice affected neither viral clearance nor expansion of antigen-specific cells (Figures S2B-S2E). However, t-SNE analyses of scRNA-seq data obtained from 1,330 Zbtb7b AD and 2,154 control GP66-specific T cells at 7 dpi showed minimal overlap between the two genotypes ( Figure 2A ). Unsupervised clustering at 7 dpi identified clusters with high scores for Th1-, Tfh-, and Tcmp cell signatures among control cells (control clusters Ctrl1-2, Ctrl3-4, and Ctrl8, respectively). In contrast, the Thpok-deficient response at 7 dpi was dominated by clusters with a Th1 cell signature (clusters Zbtb7b AD 1-4, Figure 2B ), in line with the high frequency of IFNg-producing cells in response to GP66 peptide stimulation ( Figure S2F ). All Thpok-deficient clusters showed low scores for the Tcmp cell signature: although cluster Zbtb7b AD 5 showed limited expression of Bcl2 and Ccr7, it differed from the control Tcmp cell cluster Ctrl8 by its low expression of Tcf7 and Id3 and high expression of Th1 cell-associated genes Id2 or Tbx21. In agreement with these results, the number of CCR7-expressing cells was greatly reduced in Zbtb7b AD compared to control mice at 7 dpi ( Figure 2C ). Finally, the Thpok-deficient response had no Tfh component, suggesting that Thpok was needed for Tfh cell differentiation. We confirmed this in separate experiments (unpublished data). Thus, Thpok is necessary for the emergence of the Tcmp cell gene signature.
Cell-Intrinsic Thpok Is Required for the Generation of CD4 + Memory T Cells The absence of cells with a high Tcmp signature score in Thpokdeficient mice prompted us to analyze the role of Thpok in memory CD4 + T cell development and maintenance. WT mice clear LCMV Arm by 7 or 8 dpi and generate populations of virus-specific CD4 + and CD8 + memory T cells (Matloubian et al., 1994) .
Analyses performed 90 days after LCMV Arm infection showed lower numbers of CD4 + but not CD8 + T cells in Zbtb7b AD than in control animals (we evaluated the CD8 + T cell response by staining for the virus-derived GP33 peptide complexed to H-2D b MHC-I molecules; Figures 3A and 3B ). This suggested that Thpok was needed for CD4 + T cell memory. Normally, LCMV Arm infection results in durable LCMV immunity, including against the clone 13 strain that establishes chronic infection in non-immune mice. To evaluate the role of Thpok in immune memory, we compared the responses of Zbtb7b AD and control mice to re-challenge by LCMV clone 13 more than 90 days after infection with LCMV Arm. Thpok-deficient mice re-challenged with clone 13 showed impaired viral clearance ( Figure 3C ), similar to the impaired clearance in MHC II-deficient mice that lack CD4 + T cells ( Figure S2G ), and they had reduced numbers of both CD4 + and CD8 + LCMV-responsive T cells ( Figure 3D ).
Although germline Zbtb7b disruption had been reported to directly affect CD8 + T cell memory responses (Setoguchi et al., 2009) , it was unlikely that the effect on CD8 + T cells from Zbtb7b AD mice was cell intrinsic because only 25%-30% of them expressed Cre ( Figure S2C ). To address this, we generated mixed bone-marrow chimeras combining allelically marked ''tester'' (either Zbtb7b AD or control [Zbtb7b +/+ Tnfrsf4-cre + ]) and WT competitor components ( Figure 3E ). Zbtb7b AD CD4 + T cells were out-competed by their WT counterparts at 90 dpi.
( Figure 3F ) and remained so when chimeric mice were re-challenged with LCMV clone 13 ( Figure 3G ); this indicates a cellintrinsic requirement for the generation of memory CD4 + T cells. In contrast, Zbtb7b AD CD8 + T cells competed normally with WT cells; this indicated that, in addition to its cell-intrinsic effect on CD4 + T cell memory, Thpok is necessary for CD4 + T cell help with CD8 + T cell responses (Laidlaw et al., 2016) . We next analyzed the Thpok-deficient, antigen-specific ''memory'' cells that persisted several weeks after resolution of LCMV Arm infection. These cells had reduced CD4 surface expression ( Figure S3A ), consistent with the way Thpok promotes Cd4 expression by antagonizing the Cd4 transcriptional silencer (Muroi et al., 2008; Wildt et al., 2007) . Indeed, disrupting the Cd4 silencer in Zbtb7b AD cells efficiently sustained Cd4 expression; however, it failed to reconstitute normal memory populations ( Figures 3H and 3I ). Thus, although CD4 expression is important for CD4 + T cell homeostasis in vivo (Wang et al., 2001) , the impact of Thpok on memory CD4 + T cell generation is independent of its effect on CD4 expression. We also noted that the GP66-specific Thpok-deficient population included an IL-7Ra lo KLRG1 hi component typical of short-lived terminally differentiated effectors (Kaech et al., 2003) ( Figure 4A ). This skewing toward effector differentiation was cell-intrinsic; it was observed both in mixed bone-marrow chimeras and in Zbtb7b AD CD4 + T cells that expressed the I-A b -GP66-specific SMARTA TCR transgene and that were adoptively transferred into LCMV-infected WT hosts ( Figure S3B ). It was not restored by enforced CD4 expression in Zbtb7b AD Cd4sil AD cells ( Figure S3C ).
Additionally, skewing toward an IL-7Ra lo KLRG1 hi phenotype (C) Serum virus titers 5 days after LCMV clone 13 re-challenge of LCMV-Arm-immunized mice (except black squares: naive WT mice 5 dpi with clone 13 as controls). Data summarize four independent experiments; each symbol represents a separate mouse (Zbtb7b AD , n = 15; Ctrl, n = 23; naive WT, n = 9). Bars denote the geometric mean; LOD = limit of detection. (D) GP66:I-A b+ and GP33:H-2D b+ T cell numbers in immune Zbtb7b AD (n = 9) or control (n = 10) mice and in naive WT mice (n = 7) at 5 dpi with LCMV clone 13. Data we performed RNA-seq on LCMV-specific T cell populations sorted 30 dpi with LCMV Arm, at which time the number of antigen-specific T cells was already lower in Zbtb7b AD than in control mice ( Figure S3E ). Principal-component analyses showed that, at 30 dpi, Thpok-deficient CD4 + T cells differed from both CD4 + and CD8 + control memory T cells ( Figure 4B ). In addition to expressing CD8-lineage genes, consistent with previous reports Vacchio et al., 2014; Wang et al., 2008a) (Figures S3F and S3G) , Thpok-deficient cells showed impaired expression of prototypical memory genes, including Ccr7, Cxcr5, Tcf7, Bcl2, or Il7r (Hale et al., 2013; Marshall et al., 2011) (Figures 4C-4E) , and of CCR7 and CXCR5 proteins ( Figure 4F) . Conversely, the Thpok-deficient cells inappropriately expressed genes, including Ifng, Tbx21, Id2, or Prdm1 (encoding the transcription factor Blimp1), that are typical of Th1 cells (Figure S3H) . Consistent with this Th1 cell effector diversion, Thpokdeficient cells had increased expression of Granzyme B ( Figures  S3H and S3I) . Thus, Thpok is necessary for the appropriate expression of a memory program in the CD4 + T cells that persist after resolution of infection.
Thpok Is Required Early During Activation for the Emergence of the Memory Program
Because scRNA-seq analyses indicated that Thpok was needed for the acquisition of the Tcmp cell signature at 7 dpi ( Figures 2B  and 2C ), we examined whether Thpok supported the maintenance of CD4 + T memory cells or preserved memory potential at the initial phase of the response. To this end, we deleted Thpok either before or 3 weeks after LCMV Arm infection by using a tamoxifen-inducible cre transgene driven by Cd4 cisregulatory elements Figure 5A ]) characteristic of dysfunctional T cells responding to chronic infection (Crawford et al., 2014; Wherry and Kurachi, 2015) . Because of this mixed gene expression pattern, we explored the population heterogeneity at 30 dpi by performing scRNA-seq. t-SNE visualization of Zbtb7b AD and control spleen GP66-specific T cells showed limited overlap between the two genotypes ( Figure 5B ). Unsupervised clustering identified four groups of control cells at 30 dpi; cells in three of these groups (clusters Ctrl1-3) expressed markers, including Id3, Tcf7, Il7r, and Bcl2, that are typical of memory cells. The fourth cluster (Ctrl4) showed memory-Tfhcell attributes, including expression of Bcl6 but not Ccr7 (Figure 5C) Figure 5D ). Importantly, at 30 dpi, Thpok-deficient cells showed impaired IL-2 production ( Figure 5E ), a hallmark of T cell dysfunction (Crawford et al., 2014; Wherry and Kurachi, 2015) . This dysfunctional profile was maintained during recall responses; Thpok-deficient LCMV-specific CD4 + T cells showed reduced production of IL-2 and increased expression of Tim3 and 2B4 after clone 13 re-challenge ( Figures S5A and S5B) . We conclude from these analyses that Thpok restrains a dysfunction program resembling, but distinct from, that of exhausted T cells in chronic infections. To examine whether Thpok targets the dysfunction program during the initial phase of the immune response, we defined a dysfunction signature on Thpok-deficient (Zbtb7b AD ) cells analyzed by scRNA-seq at 30 dpi (Table S2 ) and used this signature to query scRNA-seq results from cells at 7 dpi. We found higher scores for this signature in Thpok-deficient cells than in control cells ( Figure S5C ). Accordingly, adoptive-transfer experiments showed cell-intrinsic increases in the expression of Tim3 and 2B4 and reduction in the production of IL-2 by (C) Heatmap of differential gene expression (as defined in Figure S3F ). Figure 4D ; p values are from a one-way ANOVA. Bio allele encoding a Thpok protein with a biotin acceptor site ( Figure S6A ). The Zbtb7b Bio allele was functional, as it supported CD4 + T cell development in homozygous
Zbtb7b
Bio/Bio mice ( Figure S6B) ; furthermore, the encoded protein was efficiently biotinylated in CD4 + T cells that carried the Zbtb7b
Bio allele and expressed the BirA biotin ligase from the Rosa26 locus ( Figure S6C ). Analyses of triplicate ChIP-seq samples obtained from Zbtb7b
Bio Rosa26 BirA+ CD4 + T cells identified approximately 11,000 Thpok-bound genesin effector CD4 + T cells; most of these genes recruited Thpok at promoter regions ( Figure S6D ). Consistent with a previous report (Muroi et al., 2008) , Thpok molecules bound the Zbtb7b and Cd4 loci (Figure S6E and data not shown). ChIP-seq detected Thpok binding to most of the Thpokregulated genes identified in LCMV-specific CD4 + T cells by scRNA-seq at 7 dpi ( Figure S6F ). These notably included Prdm1 and Id2, encoding two transcription factors promoting T cell effector differentiation and repressing memory development (Crotty et al., 2010; Rutishauser et al., 2009; Yang et al., 2011) (Figure 6A ). We focused on Prdm1 as a potential functional target of Thpok because its product, Blimp1, acts upstream of Id2 in T cells (Miyazaki et al., 2014; Rutishauser et al., 2009; Shaw et al., 2016 T cells at 90 dpi, and it enhanced IL-2 production ( Figures 6D  and 6E ). Mirroring these late effects on functional fitness, Prdm1 disruption fully reverted the Tim3 upregulation observed at 7 dpi in Thpok-deficient cells ( Figure S7A ), and there was a similar but incomplete effect on 2B4. In contrast, Prdm1 disruption only modestly enhanced CCR7 expression at 7 dpi and failed to restore long-term memory populations ( Figures S7B  and S7C ). These findings suggested that Thpok repression of Blimp1 expression contributes to maintaining the functional fitness of memory cells but that it does not mediate the impact of Thpok on the generation of memory precursors. In addition to having increased expression of Blimp1, Thpokdeficient CD4
+ T cells at 7 dpi had increased expression of Runx3 ( Figure S7D ), a factor expressed in CD8 + and Th1 CD4 + T cells (Djuretic et al., 2009 ) and previously shown to be a functional target of Thpok (Carpenter and Bosselut, 2010; Egawa and Littman, 2008; Kojo et al., 2017; Muroi et al., 2008; Wang et al., 2008a) . Consistent with direct transcriptional control, we found that Thpok bound the Runx3 locus ( Figure 7A ). Moreover, we noted from published ChIP-seq datasets (Mackay et al., 2016; Shan et al., 2017 ) that several genes, including Tcf7 and Ccr7, that are characteristic of memory cells could recruit Blimp1 and Runx molecules in addition to Thpok ( Figure S7E ). Consequently, we speculated that maintaining memory potential required the repression of both Prdm1 and Runx3 by Thpok.
To assess this possibility, we generated Zbtb7b
which deletion of the obligatory Runx cofactor Cbfb overcomes potential overlap of functions between Runx1-3 proteins. We could not evaluate long-term memory responses in these mice because Runx activity is needed for long-term survival of CD4 + T cells (Egawa et al., 2007) , including of memory CD4 + T cells ( Figure S7F ). Thus, we assessed LCMV-specific CD4 + T cells at 7 dpi for markers of memory potential (CXCR5 and CCR7) and of dysfunction (Tim3 and 2B4). We performed these analyses in mixed bone-marrow chimeras to avoid indirect effects of gene disruption. Figure 7D ). We conclude from these experiments that Thpok promotes the emergence and functional fitness of memory CD4 + T cell precursors by restraining the expression or activity of Blimp1 and Runx molecules.
Altogether, our findings demonstrate that the transcription factor Thpok antagonizes Blimp1 and Runx3 expression and thereby support CD4 + T cell memory potential and restrains a gene expression pattern characteristic of dysfunctional T cells. These functions of Thpok identify a shared mechanistic basis for two previously unconnected attributes of CD4 + helper T cells, ensuring their functional fitness to support long-lived immunity. been accessible to previous single-cell (Lö nnberg et al., 2017) and population-level studies (Hale et al., 2013; Marshall et al., 2011) . At the initial phase of the response, we identified characteristic Th1 and Tfh cell transcriptomic signatures, which included genes encoding prototypical fate markers (e.g., T-bet and Id2 for Th1 cells or CXCR5 and Icos for Tfh cells); these signatures were largely mutually exclusive, consistent with the idea that Th1-and Tfh-effector-cell fates show little functional overlap (Crotty, 2018) . The Tcmp cell signature was associated with memory cell markers (including Ccr7, Tcf7, or Bcl2) and excluded genes (Tbx21, Prdm1, Bcl6) that are characteristic of Th1-and Tfheffector-cell genes, supporting its assignment to cells with increased memory potential. Accordingly, that signature mapped to a subset of CD4 + T cells expressing CCR7 (and also CXCR5, although in intermediate amounts) and were previously reported to contain memory precursor activity . Partial activation of the Tcmp cell signature was detected in Th1 but not Tfh cell subsets, suggesting that it identifies cells skewed toward a Th1-rather than Tfh-memory-cell potential. Consistent with this idea, two Tcmp-signature components, Klf2 and Ccr7, inhibit Tfh cell differentiation (Haynes et al., 2007; Lee et al., 2015) . The possibility of an early divergence of central and Tfh-memory-cell precursors does not exclude the fact that their differentiation programs share transcriptional regulators. Bcl6, which is needed for the generation of memory Tfh cells (He et al., 2013) , promotes the survival of all memory CD4 + T cell subsets (Ichii et al., 2007) . Additionally, Bcl6 is needed for the generation of the CXCR5 + subset during the initial CD4 + T cell response ; although this might simply reflect the importance of Bcl6 for CXCR5 expression, it could also indicate its involvement in the emergence of CD4 + T cell memory, in addition to its involvement in long-term memory cell survival.
In addition to its cell-intrinsic effect on CD4 + T cell memory, Thpok is needed for CD4 + T cell help for CD8 + T cell memory, a function critical for long-term immunity (Shedlock and Shen, 2003; Sun and Bevan, 2003) . To account for CD4 + T cell help for CD8 + T cells, others have proposed several non-mutually exclusive mechanisms, including IL-2 production and the ''licensing'' of dendritic cells, through CD40 signaling, for the provision of memory-inducing signals to CD8 + T cells (Laidlaw et al., 2016; MacLeod et al., 2009 ). Both IL-2 secretion and expression of CD154, the ligand for CD40, depend on Thpok, accounting at least in part for its contribution to CD4 + T cell help with the generation of memory CD8 + T cells.
Thpok protects the functional fitness of CD4 + memory cells by restraining a 'dysfunction' gene-expression program that shares features with the 'exhausted' state of T cells subject to chronic antigen stimulation; these features include impaired IL-2 production and dependence on Blimp1 (Crawford et al., 2014; Shin et al., 2009; Wherry and Kurachi, 2015) . However, this dysfunction pattern differs from conventional exhaustion in that it emerges despite antigen clearance, e.g., in mixed bone marrow chimeras or adoptively transferred cells; accordingly, it is not accompanied by PD1 expression, a hallmark of recent antigen engagement (Agata et al., 1996) . Additionally, the Thpokrepressed dysfunction pattern is distinct from the cytotoxic diversion we and others previously identified in Thpok-deficient CD4 + T cells Reis et al., 2013; Vacchio et al., 2014; Wang et al., 2008a) , most notably because the former depends on Blimp1, whereas the latter depends on Runx activity.
Repression of Blimp1-and Runx3-encoding genes mediated the impact of Thpok on the emergence and functional fitness of memory CD4 + T cells. Our observation that Thpok binds within or near both loci supports the possibility that their repression by Thpok is, at least in part, direct. Thpok repression of Blimp1 feeds into a negative regulatory loop whereby Bcl6 and Blimp1 inhibit each other's expression (Crotty et al., 2010) , previously characterized in differentiating CD4 + effectors. In addition, we found that Thpok binds the Bcl6 gene (unpublished data), whereas Runx3 was reported to shift the Bcl6-Blimp1 equilibrium toward Blimp1 expression (Shan et al., 2017) so that its repression could reinforce direct effects of Thpok on the Bcl6-Blimp1 loop. Together, these observations support the idea that Thpok serves at multiple entry points to shift the Bcl6-Blimp1 loop to restrain Blimp1. In summary, the present study identified a Thpok-operated checkpoint controlling both the emergence of CD4 + memory cells and their functional fitness, two previously unconnected aspects of CD4 + T cells responses. Although Thpok is expressed in all conventional CD4 + T cells, it is sensitive to both antigenic stimulation (He et al., 2008; Wang et al., 2008a) and environmental factors, as was recently shown of gut microbial metabolites (Cervantes-Barragan et al., 2017; Reis et al., 2013) . Thus, the importance of Thpok in CD4 + T cell memory and functions identifies this factor as a potential research target that could enhance responses to immunization strategies against infections or cancer.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: ) from SMARTA TCR transgenic mice (Zbtb7b AD or controls) were intra-venously injected into CD45 congenic recipients, which were infected with LCMV Arm 24 hours later. For mixed bone marrow chimera experiments, T cell-depleted (Pan T Dynal kit, Invitrogen) bone marrow cells were prepared from CD45 disparate mice, mixed together at various ratios (from 1:1 to 1:3), and injected into lethally irradiated (900 rads) CD45.1 recipients. Chimeric animals were infected eight weeks after reconstitution. In experiments using Cd4
ERT2Cre animals, gene disruption was induced by tamoxifen gavage (5mg/mouse/day for 4 consecutive days) before or 3 weeks after LCMV Arm infection. Chimerism was calculated as the ratio of tester over competitor cells within the population of interest.
Determination of Virus Titers
Serum from infected animals was isolated from peripheral blood by centrifugation and stored at À80 C. Viral RNA was extracted with PureLink Viral RNA column (Invitrogen) according to the manufacturer instructions, reverse-transcribed (Thermoscript, Invitrogen), and quantified by real-time PCR with SYBR green dye (Invitrogen) on a QuantStudio 6 Flex system (Applied Biosystems), using primers specific for the LCMV GP gene (McCausland and Crotty, 2008 ) (Fwd-GCAACTGCTGTGTTCCCGAAAC, Rev-CATT CACCTGGACTTTGTCAGACTC). For each experiment, the limit of detection (LOD) of the assay was determined using the serum of non-infected animals.
Antibodies
Antibodies for the following specificities were purchased either from Becton Dickinson PharMingen, Biolegend or ThermoFisher Ebiosciences: CD4 (RM4.4 or GK1.5), CD8a (53-6-7), CD45.2 (104), CD45.1 (A20), TCRb (H57-597), CD5 (53-7.3), B220 (RA3-6B2), IFNg (XMG1.2), IL-2 (JES6-5H4), CD44 (IM7), IL-7Ra (A7R34), KLRG1 (2F1), CCR7 (4B12), CXCR5 (SPRCL5), Tim3 (RMT3-23), 2B4 (R244F4), CXCR6 (SA051D1), streptavidin. MHC tetramers loaded with the LCMV GP33 or GP66 peptides were obtained from the NIH Tetramer Core Facility.
Cell Preparation and Staining
Spleen cells were prepared and stained as previously described (Ciucci et al., 2017) . Surface staining with GP66:I-A b tetramer or for CCR7 or CXCR5 was performed at 37 C, and staining with GP33:H-2D b tetramer at 4 C, for 1 hour prior to staining with other antibodies. Cytokine staining was performed after 5 hours on splenocytes incubated in the presence of GP66 (GLKGPDIYKGVYQFKS VEFD, 2 mg/mL) or GP33 (KAVYNFATM, 0.2 mg/mL) peptides (Anaspec) and Golgi Stop (Crawford et al., 2014) .
Flow cytometry data was acquired on LSR II or LSR Fortessa cytometers (BD Biosciences) and analyzed with FlowJo software (TreeStar). Dead cells and doublets were excluded by LiveDead staining (Invitrogen) and forward scatter height by width gating. Except if otherwise mentioned, numbers in the cytometry plot are percentages of cells in the gates. Cell sorting was performed on a FACSAria or FACS Fusion (BD Biosciences). Because of the effect of Thpok-deletion on the expression of CD4 and CD8a, analyses and purification of GP66-specific cells were performed without gating for CD4 and CD8a expression.
Population RNA-Seq RNA from GP66:I-A b+ and GP33:H-2D b+ T cells, sorted from the spleen of LCMV-infected mice at d30 p.i., was isolated using the RNeasy Plus Micro kit (QIAGEN). Quality control was performed by bioanalyzer (Agilent), and RNA samples with a RNA integrity number (RIN) > 8 were processed for library preparation using SMARTer Ultra Low Input reagent (Takara) and Nextera XT DNA (Illumina) library preparation kits. Libraries were sequenced with paired-end reads of 126bp on a HiSeq2500 sequencer (Illumina) to reach 50 million read pairs per sample. For each cell subset and genotype, data are derived from three distinct mice, with separate processing from cell sorting to sequencing. Raw RNaseq fastq reads were trimmed with Trimmomatic and aligned to mouse genome (mm10) using STAR (v. 2.4.0h). Gene-assignment and count of RNA reads were performed with HTseq . Further analyses were performed with R software and differentially expressed genes were identified using DESeq2 using the Wald test (FDR < 0.01).
Generation of a Zbtb7b
Bio Genetically Targeted Allele Specific sgRNAs targeting the 3 0 end of the Zbtb7b open reading frame were designed using the online tool MIT CRISPR Design (crispr.mit.edu) and produced in vitro using MEGAshortscript T7 transcription Kit (Thermo Fisher Scientific). A 153bp double stranded template containing the composite linker-biotin acceptor sequence agcatgcgctcgggtggaGGCCTGAACGACATCTTCGAGGCTCA GAAAATCGAATGGCACGAA (one-letter code amino acid sequence smrsggGLNDIFEAQKIEWHE, biotin acceptor peptide sequence in uppercase letters) flanked by 45bp left and right Thpok homology regions was synthesized as Ultramer DNA oligo (Integrated DNA Technologies). sgRNAs, dsDNA donor template and Cas9 mRNA (TriLink Biotechnologies) were microinjected into zygotes from C57BL/6Ncr mice at the one-cell stage to generate the Zbtb7b Bio allele.
ChIP-Sequencing Splenic CD4 + T cells from Zbtb7b
Bio/+ Rosa26 BirA or Rosa26 BirA animals were enriched using Dynabeads Untouched Mouse CD4 cells kit (Invitrogen) and stimulated with anti-CD3 (1 mg/mL), anti-CD28 (3 mg/mL) and IL-12 (10ng/mL) for 3 days and then with IL-2 (100ng/mL) for another day. Live cells were sorted, washed in PBS and fixed in 1% formaldehyde-containing PBS for 5 min at 37 degrees. Following quenching with 0.125M glycine, cells pellets were snap-frozen on dry ice and stored at À80 C. Frozen fixed cells were then lysed in 1% SDS RIPA buffer (20 mM Tris-HCl pH 7.6, 2 mM EDTA, 150 mM NaCl, 0.1% sodium deoxycholate, 1% Triton X-100) for 30 min at 4 C, spun down and sonicated in 0.1% SDS RIPA buffer using a Qsonica Q800R sonicator (30 s on, 59 s off, 85% amplitude) to obtain a sheared chromatin with an average size of 200bp. Sheared chromatin was pre-cleared with protein-A magnetic beads (Invitrogen 10001D) followed by immunoprecipitation with M280 Streptavidin beads (Invitrogen 11205D). After washing, immunoprecipitated chromatin was reverse-crosslinked by overnight incubation at 70 C in 50nM 50mM Tris-HCl pH 8., 10mM EDTA, 1% SDS buffer. DNA was subsequently treated with proteinase K and RNase (both at 0.2mg/mL) before purification using the QIAquick PCR purification kit (QIAGEN).
DNA was processed for library preparation using the Accel-NGS 2S DNA reagent (Swift). Libraries were sequenced (75bp singleended reads) on a NextSeq sequencer (Illumina). Raw fastq reads were trimmed based on quality score (Phred > 32) and aligned to mouse genome (mm10) using Bowtie on Partek Flow on the National Institutes of Health high-performance computing Biowulf cluster. Peak calling was performed with MACS2 comparing the ChIP samples from the Zbtb7b
Bio Rosa26 BirA chromatin to the Rosa26
BirA chromatin (broad peak, qvalue < 0.1). Further analyses were performed with R software with the ChIPseeker package . The Cbfb (Shan et al., 2017) and Blimp1 (Mackay et al., 2016) datasets were obtained from the gene expression omnibus (respectively accession GSE81888 and GSE79339) and aligned to the mouse genome (mm10 release) using the Bowtie package on the Partek Flow server.
Single-Cell RNA-seq 5000-10000 splenic T cells (either a mix of CD4 + and CD8 + T cells or GP66:I-A b+ T cells, as indicated in Figures) were sorted from LCMV infected mice, loaded onto a 10X Chromium platform to generate cDNAs carrying cell-and transcript-specific barcodes that were used to construct sequencing libraries using the Chromium Single Cell 3 0 Library & Gel Bead Kit v2 according to the manufacturer instructions. Libraries were sequenced on multiple runs of Illumina NextSeq using paired-end 26x98bp or 26x57bp in order to reach a sequencing saturation greater than 70%, resulting in at least 50,000 reads/cell. Single-cell sequencing files were processed, and count matrixes extracted using the Cell Ranger Single Cell Software Suite (v1.3.1). Further analyses were performed in R using the Seurat package (Butler et al., 2018 ) (2.3.0).
Data was pre-processed by removing genes expressed in fewer than 2 cells and excluding cells expressing fewer than 500 genes, or more than 10% mitochondrial genes. Reduction of data dimensionality was performed on the first 20 principal components (PC) calculated on the highly variable genes for each pre-processed dataset.
To define gene expression signatures, we first clustered d7 p.i CD44 hi datasets (including both CD8 + and CD4 + T cells) and defined as CD4 + clusters those clusters scoring high for Cd4 and negative or low for Cd8a. Cells from these clusters were extracted from the whole set. Highly variable genes were re-defined on the selected cells and Cd4-expressing populations were clustered. For each cluster, a cluster-specific gene signature was defined using the FindAllMarkers function selecting only positively enriched genes. The final Th1, Tfh, Tcmp, Treg and memory cell signatures were defined as the intersection of matching cluster-specific gene signatures identified in the two independent replicates. Gene signature scores were calculated on regressed datasets (regression of the number of UMI and percentages of mitochondrial genes with ScaleData function) using the AddModuleScore function. For analyses of Thpok-deficient and control cells, clustering was performed separately for each sample, and further analyses, including t-SNE visualization, were performed after merging datasets using the MergeSeuratObjects function. Clusters representing less than 1% of each population (which corresponds to the expected duplicate capture rate) where excluded from downstream analyses.
QUANTIFICATION AND STATISTICAL ANALYSIS
Except for deep-sequencing data, statistical significance was calculated with Prism software. Except where otherwise indicated in figure legends, error bars in graphs indicate standard deviation and statistical comparisons were done by unpaired two-sided Welch's t test.
DATA AND SOFTWARE AVAILABILITY
The accession numbers for the sequence data reported in this paper are : GEO:GSE116506,GSE116519, GSE121002 for Thpok ChIP-seq, RNA-seq, and single-cell RNA-seq, respectively. All other data and code are available upon request.
